Development of defined media for the serum-free expansion of primary keratinocytes and human embryonic stem cells.
Primary keratinocyte (Kc) cells and human embryonic stem (hES) cells are routinely propagated on a mouse fibroblast feeder layer in media containing fetal bovine serum or other nondefined factors. One disadvantage of using these nondefined factors is that they may inadvertently contaminate the culture system with infectious agents; thus, there remains a need to develop safe culture conditions free from poorly defined and/or animal products. Our laboratory has discovered that growth factors (GFs) and vitronectin (VN) can bind to each other resulting in synergistic short-term functional effects in several cell types. The aim of the current study was to determine whether primary Kc and hES cells can be established and serially propagated serum-free using medium containing VN, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 (VN:GF). Here we demonstrate that primary Kc cells can be isolated, established, serially propagated, and re-form an epidermal layer using the VN:GF combination. Additionally, cell proliferation studies indicate that the Kcs proliferate using the VN:GF combination at a rate comparable to cells grown using serum. Similarly, we verified that this VN:GF combination could be employed for the serial propagation of hES cells. Importantly, both the Kc and hES cells retain their undifferentiated phenotype when cultured using the VN:GF combinations as a serum-free medium for up to 4 passages for Kc and at least 10 passages for hES cells as indicated by the expression of a range of cell surface markers. This study demonstrates that the novel, fully defined VN:GF medium is a viable alternative to media containing serum and highlights the potential of this technology for generating therapeutically viable cells and tissues.
Richards
Sean
S
Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia. s2.richards@qut.edu.au
Leavesley
David
D
Topping
Gemma
G
Upton
Zee
Z
D000818:Animals; D049109:Cell Proliferation; D002478:Cells, Cultured; D003470:Culture Media / Q000378:metabolism; D016895:Culture Media, Serum-Free / Q000378:metabolism*; D053595:Embryonic Stem Cells / Q000166:cytology*; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D015603:Keratinocytes / Q000166:cytology*; D051379:Mice; D012867:Skin / Q000378:metabolism; D023822:Tissue Engineering / Q000379:methods; D019096:Vitronectin / Q000378:metabolism
D003470:Culture Media; D016895:Culture Media, Serum-Free; D036341:Intercellular Signaling Peptides and Proteins; D019096:Vitronectin; D007334:Insulin-Like Growth Factor I